Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Corbett

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
CNS Drugs|September 3, 2010
Management of neuropsychiatric symptoms in people with dementiaClive Ballard, Anne Corbett
Evidence-Based Medicine|December 25, 2015
Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approachesAnne Corbett, Clive Ballard
International Journal of Older People Nursing|September 3, 2011
Information provision services in dementia careAnne Corbett, Clive Ballard
Expert Opinion on Investigational Drugs|July 2, 2013
Is a potential Alzheimer's therapy already in use for other conditions? Can medications for hypertension, diabetes and acne help with the symptoms?Anne Corbett, Clive Ballard
The American Journal of Psychiatry|January 7, 2012
Antipsychotics and mortality in dementiaAnne Corbett, Clive Ballard
International Psychogeriatrics|March 21, 2020
Reducing psychotropic drug use in people with dementia living in nursing homesClive Ballard, Anne Corbett
The Lancet. Healthy Longevity|August 5, 2023
Antipsychotic drug presribing in dementia: changes from the pandemicClive Ballard, Anne Corbett
Evidence-Based Medicine|March 19, 2014
The value of vitamin E as a treatment for Alzheimer's disease remains unproven despite functional improvement, due to a lack of established effect on cognition or other outcomes from RCTsAnne Corbett, Clive Ballard
Evidence-Based Medicine|September 7, 2012
A small proportion of people with dementia and neuropsychiatric symptoms experience clinically significant worsening when antidepressants are discontinuedClive Ballard, Anne Corbett
Current Opinion in Psychiatry|March 27, 2013
Agitation and aggression in people with Alzheimer's diseaseClive Ballard, Anne Corbett
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
CNS Drugs|September 3, 2010
Management of neuropsychiatric symptoms in people with dementiaClive Ballard, Anne Corbett
Evidence-Based Medicine|December 25, 2015
Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approachesAnne Corbett, Clive Ballard
International Journal of Older People Nursing|September 3, 2011
Information provision services in dementia careAnne Corbett, Clive Ballard
Expert Opinion on Investigational Drugs|July 2, 2013
Is a potential Alzheimer's therapy already in use for other conditions? Can medications for hypertension, diabetes and acne help with the symptoms?Anne Corbett, Clive Ballard
The American Journal of Psychiatry|January 7, 2012
Antipsychotics and mortality in dementiaAnne Corbett, Clive Ballard
International Psychogeriatrics|March 21, 2020
Reducing psychotropic drug use in people with dementia living in nursing homesClive Ballard, Anne Corbett
The Lancet. Healthy Longevity|August 5, 2023
Antipsychotic drug presribing in dementia: changes from the pandemicClive Ballard, Anne Corbett
Evidence-Based Medicine|March 19, 2014
The value of vitamin E as a treatment for Alzheimer's disease remains unproven despite functional improvement, due to a lack of established effect on cognition or other outcomes from RCTsAnne Corbett, Clive Ballard
Evidence-Based Medicine|September 7, 2012
A small proportion of people with dementia and neuropsychiatric symptoms experience clinically significant worsening when antidepressants are discontinuedClive Ballard, Anne Corbett
Current Opinion in Psychiatry|March 27, 2013
Agitation and aggression in people with Alzheimer's diseaseClive Ballard, Anne Corbett
Pageof 19